Eli Lilly To Pay $29 Million To Settle Claims Drugmaker Bribed Foreign Officials

Drug Giant Under Fire Over Bribery Allegations
This Tuesday, July 17, 2012, photo shows the Eli Lilly corporate headquarters in Indianapolis. Eli Lilly and Co.'s second-quarter net income tumbled 23 percent on an expected drop in sales for its antipsychotic Zyprexa, but the performance topped Wall Street expectations, and the drugmaker raised its 2012 earnings forecast. The Indianapolis company said Wednesday, July 25, 2012, that sales for Zyprexa, its all-time top-selling drug, sank 73 percent to $379.5 million in the quarter.(AP Photo/Michael Conroy)
This Tuesday, July 17, 2012, photo shows the Eli Lilly corporate headquarters in Indianapolis. Eli Lilly and Co.'s second-quarter net income tumbled 23 percent on an expected drop in sales for its antipsychotic Zyprexa, but the performance topped Wall Street expectations, and the drugmaker raised its 2012 earnings forecast. The Indianapolis company said Wednesday, July 25, 2012, that sales for Zyprexa, its all-time top-selling drug, sank 73 percent to $379.5 million in the quarter.(AP Photo/Michael Conroy)

WASHINGTON, Dec 20 (Reuters) - Pharmaceutical company Eli Lilly and Co agreed on Thursday to pay $29 million to settle civil charges that its subsidiaries made improper payments to foreign government officials to win business in Russia, Brazil, China and Poland.

Eli Lilly agreed to the settlement without admitting or denying the charges, the U.S. Securities and Exchange Commission said.

Before You Go

10. Taiwan

Countries Most Likely To Use Bribery In Business

Popular in the Community

Close

What's Hot